[go: up one dir, main page]

MX2009013535A - Empaque de tabletas medicinales. - Google Patents

Empaque de tabletas medicinales.

Info

Publication number
MX2009013535A
MX2009013535A MX2009013535A MX2009013535A MX2009013535A MX 2009013535 A MX2009013535 A MX 2009013535A MX 2009013535 A MX2009013535 A MX 2009013535A MX 2009013535 A MX2009013535 A MX 2009013535A MX 2009013535 A MX2009013535 A MX 2009013535A
Authority
MX
Mexico
Prior art keywords
pack
medicinal tablets
tablets
medicinal
ester
Prior art date
Application number
MX2009013535A
Other languages
English (en)
Inventor
Neil Hyde
Graham Cairns
John Alfred Davis
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of MX2009013535A publication Critical patent/MX2009013535A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/18Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
    • B65D81/20Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
    • B65D81/2069Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035Blister-type containers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/36Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Se describe un empaque oclusivo de oxígeno y agua. El empaque abarca una atmósfera inerte que contiene, tabletas medicinales, en donde las tabletas contienen buprenorfina o una sal o éster de los mismos.
MX2009013535A 2007-06-13 2008-05-14 Empaque de tabletas medicinales. MX2009013535A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0711376A GB2450117A (en) 2007-06-13 2007-06-13 A water- and oxygen-occlusive blister tablet pack
PCT/GB2008/001659 WO2008152347A2 (en) 2007-06-13 2008-05-14 Pack of medicinal tablets

Publications (1)

Publication Number Publication Date
MX2009013535A true MX2009013535A (es) 2010-02-22

Family

ID=38331999

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013535A MX2009013535A (es) 2007-06-13 2008-05-14 Empaque de tabletas medicinales.

Country Status (16)

Country Link
US (1) US8697718B2 (es)
EP (1) EP2155139B1 (es)
CN (1) CN101715337A (es)
AR (1) AR066975A1 (es)
AU (3) AU2008263682A1 (es)
BR (1) BRPI0812476A2 (es)
CA (1) CA2690036C (es)
CL (1) CL2008001744A1 (es)
ES (1) ES2626628T3 (es)
GB (1) GB2450117A (es)
MX (1) MX2009013535A (es)
NZ (1) NZ581604A (es)
PE (1) PE20090373A1 (es)
TW (1) TWI527579B (es)
WO (1) WO2008152347A2 (es)
ZA (1) ZA200908588B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53995B1 (sr) 2011-09-19 2015-10-30 Orexo Ab Nove farmaceutske kompozicije, otporne na zloupotrebu, za tretman zavisnosti od opioida
CN108079221A (zh) * 2018-02-27 2018-05-29 湖南尔康制药股份有限公司 一种维c银翘泡腾片
CN108313367A (zh) * 2018-02-27 2018-07-24 湖南尔康制药股份有限公司 一种充惰性气体包装的维c银翘片

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549204A (en) * 1992-02-26 1996-08-27 Toren Consulting Pty. Ltd. Blister packs
JP2736952B2 (ja) * 1992-09-18 1998-04-08 小野薬品工業株式会社 アミジノフェノール誘導体およびその誘導体を有効成分として含有する薬剤
US5858490A (en) * 1993-06-10 1999-01-12 Nkk Corporation Film formed from polyethylene-2,6-naphthalate resin, process for producing said film and package using said film
CH689305A5 (de) * 1994-08-23 1999-02-15 Alusuisse Lonza Services Ag Blisterpackung.
US5799463A (en) * 1996-05-28 1998-09-01 Mitsubishi Gas Chemical Company, Inc. Method for preservation of article
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
PL354872A1 (en) * 1999-10-23 2004-03-08 Alkaloid Ad Oral dosage form comprising a salt of morphine or a morphine derivative
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
US7025992B2 (en) * 2001-02-14 2006-04-11 Gw Pharma Limited Pharmaceutical formulations
EP1241110A1 (en) * 2001-03-16 2002-09-18 Pfizer Products Inc. Dispensing unit for oxygen-sensitive drugs
SI21302A (sl) * 2002-10-11 2004-04-30 LEK farmacevtska dru�ba d.d. Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino
WO2004064809A1 (en) * 2003-01-22 2004-08-05 Sandoz Ag Solid pharmaceutical composition comprising ramipril
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
CA2553724A1 (en) * 2004-02-03 2005-08-18 Abbott Laboratories Aminobenzoxazoles as therapeutic agents
ATE412404T1 (de) * 2004-06-02 2008-11-15 Galephar M F Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
CA2589283A1 (en) * 2004-12-27 2006-07-06 King Pharmaceuticals Research And Development, Inc. Oxygen-impervious packaging and methods for storing thyroid hormone
TWI318571B (en) * 2005-06-10 2009-12-21 Lilly Co Eli Formulation of a thienopyridine platelet aggregation inhibitor
US8148356B2 (en) * 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
DE502005011092D1 (de) * 2005-10-05 2011-04-21 Berlin Chemie Ag Pharmazeutische Schutzverpackung
WO2007084247A2 (en) * 2005-12-28 2007-07-26 Alza Corporation Stable therapeutic formulations
EP1993607A4 (en) * 2006-01-10 2012-03-28 Pipex Inc PHARMACEUTICAL COMPOSITIONS AND METHODS FOR OBTAINING AND MAINTAINING A TARGETABLE, STABLE COPPER RATE AND PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASES RELATED TO SERIAL COPPER RATE

Also Published As

Publication number Publication date
WO2008152347A2 (en) 2008-12-18
US20100292265A1 (en) 2010-11-18
TWI527579B (zh) 2016-04-01
CA2690036A1 (en) 2008-12-18
ZA200908588B (en) 2011-02-23
US8697718B2 (en) 2014-04-15
CN101715337A (zh) 2010-05-26
WO2008152347A3 (en) 2009-04-23
EP2155139A2 (en) 2010-02-24
GB0711376D0 (en) 2007-07-25
CA2690036C (en) 2016-07-05
AU2014203766A1 (en) 2014-07-31
TW200911217A (en) 2009-03-16
AU2008263682A1 (en) 2008-12-18
GB2450117A (en) 2008-12-17
AR066975A1 (es) 2009-09-23
NZ581604A (en) 2012-08-31
CL2008001744A1 (es) 2009-05-22
EP2155139B1 (en) 2017-04-05
PE20090373A1 (es) 2009-04-01
AU2014203766B2 (en) 2016-06-09
AU2016203632A1 (en) 2016-06-23
ES2626628T3 (es) 2017-07-25
BRPI0812476A2 (pt) 2014-12-02

Similar Documents

Publication Publication Date Title
TWI366567B (en) Bicyclic heterocycles as hiv integrase inhibitors
IL179161A0 (en) Hiv integrase inhibitors: cyclic pyrimidinone compounds
EP1756069A4 (en) HIV INTEGRASE INHIBITORS
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
IL177189A0 (en) Hiv integrase inhibitors
TN2012000195A1 (en) Solid dispersion of rifaximin
TN2012000248A1 (en) Novel spiropiperidine compounds
IL177858A0 (en) Hiv integrase inhibitors
TN2011000291A1 (en) Purine compounds
SI1948666T1 (sl) Hiv integrazni inhibitorji
WO2008096736A1 (ja) ベンゾトリアゾール化合物含有組成物及び該組成物を用いてなる発光素子
UA107476C2 (uk) Фармацевтична субстанція на основі мітохондріально адресованих антиоксидантів
MX2009013535A (es) Empaque de tabletas medicinales.
EP1910363A4 (en) INHIBITORS OF HIV INTEGRASE
WO2008096742A1 (ja) インダゾール化合物含有組成物及び該組成物を用いてなる発光素子
AU303806S (en) Power pack for dentistry applications
PH12013500210A1 (en) Highly crystalline valsartan
ZA200711048B (en) Tablet containing hardly soluble active incredient
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
PL1865931T3 (pl) Plaster przezskórny
DE602006008339D1 (en) Zolpidemtabletten
WO2009054483A1 (ja) サリューシン-βを含む医薬
EP1910356A4 (en) HIV integrase
WO2005074929A3 (en) Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
ZA200609935B (en) Bicyclic heterocycles as HIV integrase inhibitors

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: RB PHARMACEUTICALS LIMITED.*

FG Grant or registration